Prevalence and clinical correlates of medical comorbidities in patients with bipolar I disorder: Analysis of acute-phase data from a randomized controlled trial

Journal of Clinical Psychiatry

Volumn 67, Issue 5, 2006, Pages 783-788

  Thompson, Wesley K ^a,b   Kupfer, David J ^a   Fagiolini, Andrea ^a   Scott, John A ^a   Frank, Ellen ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CENTRAL STIMULANT AGENT; HYPNOTIC AGENT; LAMOTRIGINE; LITHIUM; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRANYLCYPROMINE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM; VALPROIC ACID;

ADULT; ANAMNESIS; ARTICLE; BECH-RAFAELSEN MANIA SCALE; BIPOLAR I DISORDER; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DEPRESSION; DISEASE SEVERITY; FEMALE; HAMILTON SCALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MANIA; PREVALENCE; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; RANDOMIZED CONTROLLED TRIAL; SCHIZOAFFECTIVE PSYCHOSIS; SCORING SYSTEM;

EID: 33745395221     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v67n0512     Document Type: Article

References (17)

1. Sharma R, Markar HR. Mortality in affective disorder. J Affect Disord 1994;31: 91-96
2. Sharma R, Markar HR, Ballenger JC. Mortality in affective disorder. In: Talbott JA, ed. Year Book of Psychiatry and Applied Mental Health. Chicago, Ill: Mosby Year Book, Inc; 1996:296-297
3. Angst F, Stassen HH, Clayton PJ, et al. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord 2002;68:167-181
4. Cassidy F, Ahearn E, Carroll B. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry 1999;156: 1417-1420
5. Fagiolini A, Frank E, Houck PR, et al. Prevalence of obesity and weight change during treatment in patients with bipolar I disorder. J Clin Psychiatry 2002;63:528-533
6. Fagiolini A, Kupfer DJ, Houck PR, et al. Obesity as a correlate of outcome in patients with bipolar I disorder. Am J Psychiatry 2003;160:112-117
7. Frank E, Swartz HA, Mallinger AG, et al. Adjunctive psychotherapy for bipolar disorder: effects of changing treatment modality. J Abnorm Psychol 1999;108:579-587
8. Frank E, Kupfer DJ, Thase ME, et al. Two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder. Arch Gen Psychiatry 2005;62:996-1004
9. Spitzer R, Endicott J, Robins E. Research Diagnostic Criteria: rationale and reliability. Arch Gen Psychiatry 1978;35:773-782
10. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56-62
11. Bech P, Bolwig TG, Kramp P, et al. The Bech-Rafaelsen Mania Scale and the Hamilton Depression Scale. Acta Psychiatr Scand 1979;59:420-430
12. Thase ME, Carpenter L, Kupfer DJ, et al. Clinical significance of reversed vegetative subtypes of recurrent major depression. Psychopharmacol Bull 1991;27:17-22
13. Parkerson GR, Broadhead E, Tse CK. The Duke Severity of Illness Checklist (DUSOI) for measurement of severity and comorbidity. J Clin Epidemiol 1993;46:379-391
14. McCullagh P, Nelder JA. Generalized Linear Models. 2nd ed. London, UK: Chapman and Hall; 1989
15. Katon WJ. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biol Psychiatry 2003;54:216-226
16. Sonino N, Fava GA. Psychiatric disorders associated with Cushing's syndrome: epidemiology, pathophysiology and treatment. CNS Drugs 2001;15:361-373
17. Moniwa E, Lee TW, Lofchy J. Revisiting the diagnostic challenges of secondary mania and bipolar disorder in a patient with borderline hyperthyroidism. Can J Psychiatry 2004;49:863-864